Aligos Therapeutics Inc
NASDAQ:ALGS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aligos Therapeutics Inc
NASDAQ:ALGS
|
US |
|
T
|
Telefonica SA
F:TNE2
|
ES |
|
Golden Dawn Minerals Inc
XTSX:GOM
|
CA |
|
Bayer AG
MIL:1BAYN
|
DE |
|
S
|
Simcorp A/S
CSE:SIM
|
DK |
|
Meta Materials Inc
NASDAQ:MMAT
|
CA |
|
Mediobanca Banca di Credito Finanziario SpA
MIL:MB
|
IT |
|
Beam Therapeutics Inc
NASDAQ:BEAM
|
US |
|
Secuoya Grupo de Comunicacion SA
MAD:SEC
|
ES |
|
Root Inc
NASDAQ:ROOT
|
US |
|
Biomerieux SA
PAR:BIM
|
FR |
|
B
|
BYD Co Ltd
XMUN:BY6A
|
CN |
|
B
|
Bluegreen Vacations Holding Corp
F:BCB1
|
US |
|
G
|
Goldman Sachs Group Inc
F:GOS
|
US |
|
S
|
SPAR Group Ltd
JSE:SPP
|
ZA |
|
T
|
Telefonica SA
XMUN:TNE2
|
ES |
|
Threat Protect Australia Ltd
ASX:TPS
|
AU |
|
G
|
Golden Agri-Resources Ltd
OTC:GARPY
|
SG |
|
Isuzu Motors Ltd
TSE:7202
|
JP |
|
W
|
Wise PLC
LSE:WISE
|
UK |
|
Aston Bay Holdings Ltd
XTSX:BAY
|
CA |
|
F
|
Fastenal Co
F:FAS
|
US |
|
C
|
CRH PLC
F:CRG
|
IE |
|
Euronet Worldwide Inc
NASDAQ:EEFT
|
US |
Bankruptcy Probability
Aligos Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aligos Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Aligos Therapeutics Inc
NASDAQ:ALGS
|
35.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
381.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aligos Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aligos Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
